Sort
85,873 grants matching “alzheimers”
Childhood Neurodegenerative Lysosomal Storage Disorders
$1,617,990Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Childhood Neurodegenerative Lysosomal Storage Disorders
$1,617,704Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
National Resource for Mass Spectrom of Biological Macromolecules
$1,617,191Brian T Chait · Rockefeller University · P41 · FY2017 · GM
Dementia Risk Prediction Pooling Project
$1,617,091Norrina Bai Allen · Northwestern University At Chicago · R61 · FY2020 · NS
Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials
$1,616,947Jessica Brooke Langbaum · Banner Health · R01 · FY2020 · AG
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
$1,616,919Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · AG
Basal Ganglia in Health and Disease
$1,616,888Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Community Engagement, Recruitment and Retention (CERR) Core D
$1,616,685Zhao Chen · University Of Arizona · U19 · FY2024 · AG
Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD
$1,616,243Chinedu Theresa Udeh-Momoh · Wake Forest University Health Sciences · R01 · FY2025 · AG
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
$1,616,066Stephen M Strittmatter · Yale University · U01 · FY2020 · AG
NEUROPATHOLOGY
$1,615,584Daniel W McKeel · Washington University · P50 · FY2009 · AG
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
$1,615,537David A Bennett · Rush University Medical Center · R01 · FY2009 · AG
Combinatorial Actions of Genetic Variants and Gender Bias of Alzherimer's Disease
$1,614,750Michael G Rosenfeld · University Of California, San Diego · R01 · FY2017 · AG
Johns Hopkins-Tufts Trial Innovation Center
$1,614,467Daniel F Hanley · Johns Hopkins University · U24 · FY2020 · TR
Alzheimer's Disease Research Center
$1,613,910Mary Sano · Icahn School Of Medicine At Mount Sinai · P50 · FY2013 · AG
STRESS, AGING AND WOUND HEALING
$1,613,439Ohio State University · P01 · FY2000 · AG
A Systems Approach to Targeting Innate Immunity in AD
$1,613,148Todd E. Golde · University Of Florida · U01 · FY2018 · AG
Functional analysis of glia in tauopathy
$1,613,138Mel B Feany · Brigham And Women'S Hospital · RF1 · FY2025 · AG
In vitro pharmacology, chronic toxicology, and embryo-fetal development studies to demonstrate safety of GSM-779690
$1,612,640Douglas R Galasko · University Of California, San Diego · U01 · FY2025 · AG
MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION
$1,611,954Elizabeta Gjoneska · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Illuminating neurodegenerative tauopathy from somatic genomic landscapes of single human brain cells
$1,611,000Michael B Miller · Brigham And Women'S Hospital · DP2 · FY2023 · AG
Washington University Center for Translational Neuroscience
$1,610,910David M Holtzman · Washington University · P30 · FY2006 · NS
Disrupted Lipid Metabolism in Alzheimer's Disease
$1,610,885Fei Yin · University Of Arizona · RF1 · FY2024 · AG
Design And Development Of Experimental Therapeutics
$1,610,701Nigel H. Greig · National Institute On Aging · ZIA · FY2011 · AG
Dysregulation of Cav1.2 by beta amyloid peptide
$1,610,512Johannes W Hell · University Of California At Davis · RF1 · FY2022 · AG